Advanced search×

Advances in technology improving safety and efficiency in blood-sample draw.

Ana Stankovic

MLO Med Lab Obs 43(1):18, 20 (2011) PMID 21309346

Version: za2963e q8zac q8zbf q8zc1 q8zd2 q8ze3 q8zf8 q8zgb
Buy PDF

Similar articles you may find interesting…

  1. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    J J Lin, R W RW Yon, ... J S JS Bromberg

    Transplantation 59(8):1162-71 (1995) PMID 7537394

    These results show that anti-CD2 mAbs significantly and persistently down-modulate CD2 on various T cell subpopulations. The mAbs must interact with both the CD2 receptor and an Fc gamma R. CD2 down-modulation is accompanied by changes in the array of other T cell surface receptors that may contribu...
    Buy PDF
  2. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo.
    J S JS Bromberg, K D KD Chavin, ... C F CF Barker

    Transplantation 51(1):219-25 (1991) PMID 1670971

    These results support a major role for CD2 in diverse aspects of cell-mediated immunity affecting both CD4+ and CD8+ effector T cells. The anti-CD2 mAb functions not by deleting or depleting relevant cell populations but rather by altering the array of cell surface receptors and subsequent responses...
    Buy PDF
  3. Prognostic significance of tumor infiltrating lymphocytes in melanoma.
    Alison L Burton, Brent A Roach, ... Kelly M McMasters

    Am Surg 77(2):188-92 (2011) PMID 21337878

    The prognostic significance of tumor infiltrating lymphocyte (TIL) response in cutaneous melanoma is controversial. This analysis of data from a prospective, randomized trial included patients with cutaneous melanoma > or = 1.0 mm Breslow thickness who underwent wide local excision a...
    Buy PDF